---
document_datetime: 2023-09-21 17:40:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/azarga-epar-all-authorised-presentations_en.pdf
document_name: azarga-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7788087
conversion_datetime: 2025-12-19 07:01:34.656773
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength           | Pharmaceutical Form   | Route of administration   | Packaging   | Content   | Package size   |
|-----------------|-----------------|--------------------|-----------------------|---------------------------|-------------|-----------|----------------|
| EU/1/08/482/001 | AZARGA          | 10 mg/ml + 5 mg/ml | Eye drops, suspension | Ocular use                | Bottle (PE) | 5 ml      | 1 bottle       |
| EU/1/08/482/002 | AZARGA          | 10 mg/ml + 5mg/ml  | Eye drops, suspension | Ocular use                | Bottle (PE) | 5 ml      | 3 bottles      |